Page last updated: 2024-09-03

2',3'-dideoxycytidine 5'-triphosphate and bekanamycin

2',3'-dideoxycytidine 5'-triphosphate has been researched along with bekanamycin in 1 studies

Compound Research Comparison

Studies
(2',3'-dideoxycytidine 5'-triphosphate)
Trials
(2',3'-dideoxycytidine 5'-triphosphate)
Recent Studies (post-2010)
(2',3'-dideoxycytidine 5'-triphosphate)
Studies
(bekanamycin)
Trials
(bekanamycin)
Recent Studies (post-2010) (bekanamycin)
502118439

Protein Interaction Comparison

ProteinTaxonomy2',3'-dideoxycytidine 5'-triphosphate (IC50)bekanamycin (IC50)
3-oxoacyl-[acyl-carrier-protein] synthase 3 Escherichia coli6.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Y; Li, QS; Li, ZL; Zhang, HJ; Zhu, DD; Zhu, HL1

Other Studies

1 other study(ies) available for 2',3'-dideoxycytidine 5'-triphosphate and bekanamycin

ArticleYear
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Bioorganic & medicinal chemistry, 2011, Aug-01, Volume: 19, Issue:15

    Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Urea

2011